Sino Biopharmaceutical
Sino Biopharmaceutical Limited, listed on the Hong Kong Stock Exchange under the ticker 1177, is a leading pharmaceutical conglomerate in China. The company is involved in the research, development, manufacture, and sale of a broad range of pharmaceutical products. Its core sectors include oncology, cardiovascular, hepatitis, and respiratory drugs, along with a focus on innovative and generic medicines. With a strong emphasis on R&D, Sino Biopharmaceutical aims to deliver high-quality and affordable healthcare solutions.